Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update.

Creator(s)

J K. Hicks
K Sangkuhl
J J. Swen
V L. Ellingrod
D J. Müller
K Shimoda
J R. Bishop
E D. Kharasch
T C. Skaar
Andrea Gaedigk, Children's Mercy HospitalFollow
H M. Dunnenberger
T E. Klein
K E. Caudle
J C. Stingl

Document Type

Article

Publication Date

7-1-2017

Identifier

PMCID: PMC5478479 DOI: 10.1002/cpt.597

Journal Title

Clinical pharmacology and therapeutics

Volume

102

Issue

1

First Page

37

Last Page

44

MeSH Keywords

Antidepressive Agents, Tricyclic; Pharmacogenetics; Cytocrhome P-450 CYP2D6; Cytochrome P-450 CYP2C19; Genotype

Keywords

Clinical pharmacogenetics implementation consortium; CPIC

Recommended Citation

Hicks JK, Sangkuhl K, Swen JJ, et al. Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update. Clin Pharmacol Ther. 2017;102(1):37-44. doi:10.1002/cpt.597